Gene Patents Related to Common Diseases of the Eye
Abstract:Visual impairment and blindness impose substantial morbidity and premature mortality on the population . The direct costs for vision disorders have been shown to be more than the cost of coronary heart disease, stroke, arthritis or depression and were estimated to be $9.85 billion in 2004 in Australia. Hence it is important to identify the causes of common eye diseases and understand their aetiology which in turn would allow determination of better management strategies and treatment options. Age related Macular Degeneration, Cataract, Diabetic Retinopathy, Glaucoma and uncorrected refractive errors represent the majority of the visual impairment and blindness in Australia and various parts of the world. This article reviews the gene patents available for these eye conditions and highlights the important discoveries that have so far contributed to our understanding of these diseases and provides valuable information as to where research will be heading in the future.
Keywords: AETIOLOGY; CY1B1 and LTBP2; Common Diseases; Langerhans cells; Myopia; T-lymphocytes; cataract; degeneration; dendritic cells; diabetic; diabetic retinopathy; ganglion cells; gene; glaucoma; mutant receptor displays; retinopathy
Document Type: Research Article
Publication date: December 1, 2011
- Recent Patents on DNA and Gene Sequences publishes review articles by experts on recent patents on DNA and gene sequences. A selection of important and recent patents in the field is also included in the journal. The journal is essential reading for all researchers involved in applied molecular biology.